Bacterial Retention Testing
Bacterial retention filter validation testing for safe pharmaceutical drug production
Ensure your filtration systems deliver sterile effluent under challenging conditions. Our bacterial retention testing uses a scale-down model to validate critical parameters under worst-case scenarios, managing risk and contributing to safe pharmaceutical drug production. Contact us to design and validate your filtration systems aligned with PDA Technical Report 26 and global regulatory standards.
Validate sterilizing-grade filters under worst-case conditions
- Challenge sterilizing-grade membranes under worst-case conditions to validate retention of ≥10⁷ bacteria/cm², ensuring reliable outcomes.
- Follow PDA and ASTM standards, using Brevundimonas diminuta or alternative strains justified by bioburden data.
- Test one drug product lot with three sterilizing-grade membrane lots, including size controls and viability/recovery studies.
- Simulate your drug product process conditions to provide empirical evidence to validate your sterile filtration.
Related product resources
- Tech bulletin: Effect of membrane filter pore size on microbial recovery and colony morphology
The 0.45 µm membrane filter size is the preferred choice for microbial recovery and colony morphology and has been demonstrated by comparing the effects of combinations on range of pore sizes on colony size and recovery.
- Application note: Retention of small organisms by 0.22 μm Durapore® Filter
A study on bacterial retention to determine the worst case challenge organism.
- Brochure: Global validation services
Regulatory guidance documents provide a framework to manufacturers for the production of drugs that are safe for administration to patients.
- Webinar: Navigating EU GMP Annex 1
This webinar describes a scientific, risk-based approach to change management and a roadmap for biomanufacturers to expedite changes in their post-approval processes.